This series of Transl Lung Cancer Res will evaluate current clinical evidence in the still-evolving understanding of the role of ICI in oncogene addicted NSCLC, and the potential pulmonary toxicity associated with ICI.
The knowns & unknowns of pulmonary toxicity following immune checkpoint inhibitor therapies: a narrative review
A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer
Integrating endobronchial ultrasound bronchoscopy with molecular testing of immunotherapy biomarkers in non-small cell lung cancer
Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors
The series “Lung Cancer and The Immune System” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Daniel Steinfort served as the unpaid Guest Editor for the series.